Komori
Sekisui Chemical (4204) · InitiativeRestated

Creating synergies through the integration of Sekisui Medical and EIDIA

First written in FY2018-Q1. 1 of 2 entries say "Restated". Latest entry: FY2018.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018-Q1 – FY20182017: 120172018: 12018
Same theme, other companies
Functional Integration and Domain Expansion through Reorganization within the Healthcare BusinessA theme 10 companies write about · 0 as a headwind · 10 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2018RestatedAnnual report

    「統合したエーディアの強みの一つである「がん」領域を中心に、積水メディカル、エーディアの保有技術の相互活用を推進している。」

    積水メディカルとエーディアの統合後、がん領域を含む保有技術の相互活用とシナジー創出を継続記載。
  2. FY2018-Q1First statedAnnual report

    「ライフサイエンス分野では、検査薬事業を中心に事業を展開する積水メディカル株式会社とエーディア株式会社を４月１日付けで統合し、シナジー創出の加速を図った。」

    両社を4月1日付けで統合し、ライフサイエンス分野でのシナジー創出を加速する取り組みを初めて記載。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Sekisui Chemical's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.